MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...

"OTC oral pain meds basically fall into two categories, Tylenol and NSAIDs. All NSAIDs will have a ceiling effect, i.e. taking more of that particular NSAID, or combining with a different NSAID once ...

Analgesic Therapies Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids (see Corticosteroid Therapy) can be useful for acute pain relief in patients with rheumatoid arthritis (RA). In ...

Use of OTC analgesics — including acetaminophen and NSAIDs — improves concussion symptoms and reduces recovery time in injured athletes, preliminary research suggests.

Nonnarcotic analgesics, including NSAIDs and acetaminophen, are an important pharmacological class for treating endodontic pain and reducing inflammation, according to the study authors. “There is a ...

Therefore, a combination of the two agents may offer a synergistic approach to pain relief. 9 Although there is yet no nonprescription analgesic product available in the U.S. that combines ...

Among 383,780 NSAID-naive patients, the proportion receiving prescriptions for NSAIDS increased from 0.3% within seven days to 7.8% at one year.

, NSAID use was associated with lower risk for kidney failure with KRT (HR 0.63, 95% CI 0.45 to 0.88 for women, and HR 0.77, 95% CI 0.59 to 0.99 for people with GFR <45 mL/min/1.73 m ...

Analyzing data collected from more than 55,000 women in the Nurses’ Health Study, they found that people who reported using an NSAID like ibuprofen, or acetaminophen for more than six years ...

Notably, the cohorts that use NSAID and acetaminophen did not differ statistically from one another. Interestingly, analgesic use was linked to increased levels of anti-Spike antibodies rather ...

The associations between analgesic medication use and EOC risk are shown in Table 2. In comparison with never users of any analgesic medications, women who used any type of NSAIDs, including ...

From 2006 to 2015, opioid use increased from 31.2% to 42.4% and NSAID use from 10.7% to 16.6% among patients with CKD, Rajiv Saran, MD, MS, of the Kidney Epidemiology and Cost Center, in Ann Arbor ...